Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 949

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors

Rendic, Slobodan, Carlo, Frederick J. Di·1997·Drug Metabolism Reviews
DOI 10.3109/03602539709037591
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/03602539709037591

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 213

  1. Generic F. P, 1992, FASEB J., 6, 667, 10.1096/fasebj.6.2.1537453 · DOI
  2. Black S. D, 1992, FASEB J., 6, 680, 10.1096/fasebj.6.2.1537456 · DOI
  3. 10.1007/978-1-4757-2391-5_14 · DOI · Paper page
  4. Kronbach T, 1995, Pharmacokinetics, Regulatory-Industrial-Academic Perspectives, 2nd ed, 236
  5. 10.3109/03602539508998329 · DOI
  6. 10.1016/0006-2952(92)90333-E · DOI
  7. Beaune P. H, 1993, Therapie, 48, 521
  8. Graham-Lorence S., 1996, FASEB J., 10, 206, 10.1096/fasebj.10.2.8641554 · DOI
  9. Guengerich F. P, 1992, FASEB J., 6, 745, 10.1096/fasebj.6.2.1537465 · DOI
  10. 10.1016/0928-0987(94)90074-4 · DOI
  11. Caldwell J, 1995, Pharmaceutical Forum, 4, 5
  12. 10.1016/0163-7258(95)02013-6 · DOI
  13. Yang C. S., 1992, FASEB J., 6, 737, 10.1096/fasebj.6.2.1537464 · DOI
  14. Pessayre D, 1993, Therapie, 48, 537
  15. Ortiz de Montellano P. R, 1989, TIPS Rev., 10, 354
  16. Shimada T., 1996, Drug Metab. Dispos., 24, 515
  17. 10.1159/000139376 · DOI
  18. 10.3109/03602539308993979 · DOI
  19. Guengerich F. P, 1993, Drug Metab. Dispos, 21, 1, 10.1016/S0090-9556(25)07309-X · DOI
  20. 10.1016/0960-894X(95)00048-X · DOI
  21. 10.3109/10408449509089886 · DOI · Paper page
  22. Gibaldi M, 1992, Ann. Pharmacother., 26, 121, 10.1177/106002809202600123 · DOI
  23. Gibaldi M, 1992, Ann. Pharmacother., 26, 709, 10.1177/106002809202600520 · DOI
  24. Gibaldi M, 1992, Ann. Pharmacother., 26, 255, 10.1177/106002809202600223 · DOI
  25. 10.1097/00008571-199408000-00005 · DOI
  26. 10.1089/dna.1.1989.8.1 · DOI
  27. Testa B, 1995, Biochemistry of Redox Reactions, 78
  28. 10.1097/00008571-199602000-00002 · DOI
  29. 10.1016/0378-4274(95)03523-0 · DOI
  30. 10.1016/0378-4274(95)03597-4 · DOI
  31. 10.1146/annurev.pa.35.040195.002101 · DOI
  32. 10.3109/00498259609046723 · DOI
  33. 10.1016/0378-4274(95)03600-8 · DOI
  34. 10.3109/03602539409029789 · DOI · Paper page
  35. 10.1016/0378-4274(94)90110-4 · DOI
  36. 10.3109/03602539308993982 · DOI
  37. 10.3109/03602539308993983 · DOI
  38. Fijii-Kuriyama Y., 1992, FASEB J., 6, 707
  39. 10.1038/clpt.1994.49 · DOI
  40. Curi-Pedrosa R., 1994, J. Pharmacol. Exp. Ther., 269, 384, 10.1016/S0022-3565(25)38702-1 · DOI
  41. Buening M. K., 1981, Cancer Res., 41, 67
  42. 10.1055/s-2008-1040482 · DOI
  43. 10.1093/jnci/82.16.1333 · DOI · Paper page
  44. Parke D., 1990, Acta. Pharm. Jugosl., 40, 363
  45. 10.1093/carcin/15.3.465 · DOI
  46. 10.1021/tx00043a018 · DOI
  47. 10.3109/03602539409029783 · DOI
  48. Tassaneeyakul W., 1993, J. Pharmacol. Exp. Ther., 265, 401, 10.1016/S0022-3565(25)38136-X · DOI
  49. 10.1073/pnas.86.20.7696 · DOI · Paper page
  50. 10.1016/0006-2952(94)90304-2 · DOI
  51. 10.1097/00008571-199206000-00003 · DOI · Paper page
  52. 10.1111/j.1365-2125.1995.tb04411.x · DOI
  53. 10.1016/0006-2952(87)90592-2 · DOI
  54. Bourdi M., 1994, Mol. Pharmacol., 45, 1287, 10.1016/S0026-895X(25)10602-0 · DOI
  55. Buening M. K., 1981, Cancer Res., 41, 67
  56. 10.1002/j.1552-4604.1993.tb03925.x · DOI
  57. 10.1128/AAC.36.5.942 · DOI
  58. 10.1006/abbi.1994.1099 · DOI
  59. Gallagher E. P., 1994, Cancer Res., 54, 101
  60. Roberts E. A., 1993, Drug Metab. Dispos, 21, 56, 10.1016/S0090-9556(25)07336-2 · DOI
  61. 10.1016/0006-2952(94)90363-8 · DOI · Paper page
  62. 10.1006/abbi.1994.1259 · DOI
  63. 10.3109/00498259509061837 · DOI
  64. 10.1016/0006-291X(78)90616-2 · DOI
  65. Yun C.-H., 1994, Mol. Pharmacol., 40, 679
  66. 10.1016/0006-2952(94)90097-3 · DOI
  67. de Morais S. M. F., 1995, Pharmacogenetics, 4, 285
  68. Balian J. D., 1994, Clin. Pharmacol. Ther., 55, 169
  69. 10.1016/0009-9236(95)90073-X · DOI
  70. Caraco Y., 1996, Clin. Pharmacol. Ther., 60, 369
  71. Miners J. O., 1994, Clin. Pharmacol. Ther., 55, 138
  72. 10.1021/bi00167a022 · DOI
  73. 10.3109/00498259509061850 · DOI
  74. 10.1038/clpt.1994.65 · DOI
  75. Bonnabry P., 1994, Clin. Pharmacol. Ther., 55, 139
  76. Vogt N., 1994, Clin. Pharmacol. Ther., 55, 154
  77. Karam W. G., 1996, Drug Metab. Dispos., 24, 1081, 10.1016/S0090-9556(25)08409-0 · DOI
  78. 10.1111/j.1365-2125.1994.tb04310.x · DOI
  79. 10.3109/00498257909038744 · DOI
  80. 10.1038/clpt.1985.148 · DOI
  81. 10.1016/0006-2952(94)90386-7 · DOI
  82. 10.1016/0006-2952(92)90394-X · DOI
  83. 10.1038/clpt.1993.177 · DOI
  84. 10.1016/0006-2952(94)90237-2 · DOI
  85. 10.1111/j.1365-2125.1989.tb05354.x · DOI
  86. Jaruratanasirikul S., 1994, Clin. Pharmacol. Ther., 55, 169
  87. 10.1073/pnas.81.23.7348 · DOI
  88. 10.1007/BF01740595 · DOI
  89. 10.1038/clpt.1994.53 · DOI
  90. Kenna J. G., 1994, Anaesth.-Pharmacol. Rev., 2, 29
  91. Koop D. R, 1992, FASEB J., 6, 724, 10.1096/fasebj.6.2.1537462 · DOI · Paper page
  92. 10.1016/0020-711X(94)90175-9 · DOI
  93. 10.1016/0009-9236(95)90169-8 · DOI
  94. 10.1016/0006-2952(94)90524-X · DOI
  95. 10.1016/0006-2952(93)90639-E · DOI
  96. 10.1006/abbi.1994.1280 · DOI
  97. 10.1097/00008571-199408000-00002 · DOI
  98. 10.3109/00498259409043253 · DOI
  99. 10.1016/0009-9236(95)90176-0 · DOI
  100. 10.1097/00008571-199408000-00001 · DOI · Paper page
  101. 10.1016/0960-0760(93)90152-M · DOI
  102. Maurice M., 1992, FASEB J., 6, 752, 10.1096/fasebj.6.2.1371482 · DOI · Paper page
  103. 10.1016/0003-9861(88)90655-8 · DOI · Paper page
  104. Bailey D. G., 1994, Clin. Pharmacol. Ther., 55, 165
  105. Pellinen P., 1994, Eur. J. Pharmacol., 270, 35
  106. 10.1016/0006-2952(94)90543-6 · DOI · Paper page
  107. 10.1016/0009-9236(95)90068-3 · DOI
  108. 10.1038/clpt.1994.60 · DOI
  109. Honig P., 1994, Clin. Pharmacol. Ther., 55, 165
  110. Gomez D. Y., 1994, Clin. Pharmacol. Ther., 55, 209
  111. 1994, WHO Pharm. Newslett., 3
  112. 10.1016/0006-2952(94)90071-X · DOI · Paper page
  113. 10.1097/00008571-199408000-00003 · DOI
  114. 10.1016/0006-2952(94)90387-5 · DOI
  115. Murray M., 1994, J. Pharmacol. Exp. Ther., 270, 645, 10.1016/S0022-3565(25)22422-3 · DOI
  116. 10.3109/00498259409038665 · DOI
  117. Ring B. J., 1994, Drug Metab. Dispos, 22, 352, 10.1016/S0090-9556(25)08382-5 · DOI
  118. Relling M. V., 1994, Mol. Pharmacol., 45, 352, 10.1016/S0026-895X(25)09935-3 · DOI
  119. 10.1038/clpt.1994.62 · DOI
  120. 10.1042/bst0211023 · DOI
  121. 10.1038/clpt.1994.184 · DOI · Paper page
  122. Botsch S., 1993, Mol. Pharmacol., 43, 120, 10.1016/S0026-895X(25)13410-X · DOI
  123. Imaoka S., 1990, J. Pharmacol. Exp. Ther., 255, 1385, 10.1016/S0022-3565(25)23210-4 · DOI
  124. Berson A., 1993, J. Pharmacol. Exp. Ther., 265, 366, 10.1016/S0022-3565(25)38106-1 · DOI
  125. Salcedo J. A., 1995, Clin. Pharmacol. Ther., 57, 149
  126. Chang T. K. H., 1993, Cancer Res., 53, 5629
  127. De Montelano O., 1992, FASEB J., 6, 695, 10.1096/fasebj.6.2.1537458 · DOI
  128. Ha H. R., 1992, FASEB J., 6, A1845
  129. 10.1016/0024-3205(91)90341-8 · DOI
  130. 10.1016/0006-2952(92)90068-T · DOI
  131. 10.1111/j.1365-2125.1992.tb04133.x · DOI
  132. 10.3109/00498259509061862 · DOI
  133. 10.3109/00498259509061859 · DOI
  134. Zhou-Pan X.-R., 1993, Cancer Res., 53, 5121
  135. Nakasa H., 1993, Mol. Pharmacol., 44, 216, 10.1016/S0026-895X(25)13151-9 · DOI
  136. 10.1016/0006-2952(94)90319-0 · DOI
  137. 10.1021/tx00043a018 · DOI
  138. Daikh B. E., 1994, J. Pharmacol. Exp. Ther., 271, 1427, 10.1016/S0022-3565(25)24028-9 · DOI
  139. Yu E., 1993, Mol. Biol., 27, 677
  140. 10.1006/abbi.1994.1246 · DOI
  141. 10.1111/j.1365-2125.1994.tb04397.x · DOI
  142. Raucy J. L., 1988, J. Cell Biol., 107, 195a
  143. 10.1097/00000542-199501000-00026 · DOI
  144. Adedoyin A., 1995, Clin. Pharmacol. Ther., 57, 150
  145. Ullrich V., 1990, Stroke, 21, 134
  146. Hecker M., 1989, J. Biol. Chem., 264, 141, 10.1016/S0021-9258(17)31235-8 · DOI
  147. 10.1016/0014-5793(92)80990-X · DOI
  148. Kagawa N., 1995, Cytochrome P450-Structure, Mechanism and Biochemistry, 2nd ed., 419, 10.1007/978-1-4757-2391-5_12 · DOI
  149. 10.1016/0960-0760(92)90307-5 · DOI · Paper page
  150. 10.1016/0928-0987(94)90052-3 · DOI
  151. 10.1016/0960-0760(92)90328-G · DOI
  152. 10.3109/00365528809095949 · DOI
  153. 10.1056/NEJM198908033210501 · DOI
  154. 10.1136/bmj.308.6927.503 · DOI
  155. 10.1016/0960-0760(92)90309-7 · DOI
  156. 10.1172/JCI110903 · DOI · Paper page
  157. Weber M. M., 1993, Clin. Invest., 71, 933
  158. 10.1007/BF00637598 · DOI
  159. 10.1021/bi00174a027 · DOI
  160. 10.1016/0960-0760(91)90272-7 · DOI
  161. Hosaka M., 1980, Acta Endocrinol., 94, 389, 10.1530/acta.0.0940389 · DOI
  162. Simpson E. R., 1994, Endocr. Rev., 15, 342
  163. 10.1016/0960-0760(93)90106-7 · DOI
  164. 10.1042/cs0700099 · DOI
  165. Pont A., 1982, Intern. Med., 97, 370
  166. 10.1016/0163-7827(94)00008-A · DOI
  167. 10.1006/taap.1995.1085 · DOI
  168. Donato M. T., 1995, Drug Metab. Dispos, 23, 553, 10.1016/S0090-9556(25)06619-X · DOI
  169. 10.1016/0960-0760(94)90206-2 · DOI
  170. 10.1016/0014-5793(95)00367-I · DOI
  171. Abolfathi Z., 1995, Clin. Pharmacol. Ther., 57, 221
  172. Scmider J., 1995, Clin. Pharmacol. Ther., 57, 193
  173. Lee Y. S., 1995, Clin. Pharmacol. Ther., 57, 173
  174. Brannan M. D., 1995, Clin. Pharmacol. Ther., 57, 193
  175. Jähnchen E., 1995, Clin. Pharmacol. Ther., 57, 151
  176. 10.1111/j.1476-5381.1995.tb13279.x · DOI
  177. Richardson T. H., 1995, FASEB J., 9, A1489, 10.1096/fasebj.9.14.7589991 · DOI
  178. 10.3109/00498259609046707 · DOI
  179. 10.3109/00498259609046709 · DOI
  180. 10.1016/0006-2952(95)02184-1 · DOI
  181. 10.1006/abbi.1996.0193 · DOI
  182. 10.1016/0006-2952(96)85085-4 · DOI
  183. de Groene A. M., 1996, Cancer Res., 56, 299
  184. Kumar G. N., 1996, J. Pharmacol. Exp. Ther., 277, 423, 10.1016/S0022-3565(25)12840-1 · DOI · Paper page
  185. Ebner T., 1995, Mol. Pharmacol., 48, 1078, 10.1016/S0026-895X(25)10578-6 · DOI
  186. 10.1016/0378-4274(95)03526-5 · DOI
  187. Ahmed S., 1995, Drug Design Discov., 13, 27
  188. 10.1046/j.1365-2125.1996.03178.x · DOI
  189. 10.1111/j.1365-2125.1996.tb00181.x · DOI
  190. Nunoya K. I., 1996, J. Pharmacol. Exp. Ther., 277, 768, 10.1016/S0022-3565(25)12933-9 · DOI
  191. 10.1093/carcin/17.4.809 · DOI
  192. Chiba M., 1996, Drub Metab. Dispos, 24, 307, 10.1016/S0090-9556(25)07348-9 · DOI
  193. 10.1021/tx950116m · DOI
  194. 10.1097/00004714-199512000-00002 · DOI
  195. 10.1097/00004850-199603001-00005 · DOI
  196. Pirnohamed M., 1995, J. Pharmacol. Exp. Ther., 272, 984, 10.1016/S0022-3565(25)24566-9 · DOI
  197. Quattrochi L. C., 1994, J. Biol. Chem., 269, 6949, 10.1016/S0021-9258(17)37466-5 · DOI
  198. 10.1006/abbi.1996.0161 · DOI
  199. 10.1074/jbc.271.7.3460 · DOI · Paper page
  200. Wright M. C., 1996, Hum. Exp. Pathol, 15, 204

200 of 213 shown

Cited by

See all 949

Metadata

Authors
Rendic, S., & Carlo, F. J. D.
Venue
Drug Metabolism Reviews
Publisher
Informa UK Limited
Published
1997-01
Volume
29
Issue
1-2
Pages
413-580
ISSN
  • 0360-2532
  • 1097-9883
DOI
10.3109/03602539709037591
Cited by
949
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.